PharmD Info

A forum for Indian Pharmacy Professionals

Research funding schemes, UGC Approved Journals, Project Protocols, Clinical Study Designs, Clinical Trails Registry and Regulation, Biostatistics Forum.
Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
  • User avatar
As new CIOMS reports are published, more terms and definitions will be added. At the time of writing, four new CIOMS pharmacovigilance reports are being prepared:

  • Patient Involvement in the Development and Safe Use of Medicines (CIOMS XI);
  • Benefit-Risk Balance for Medicinal Products (CIOMS XII) - this will be an update of CIOMS IV on Benefit-Risk Balance for Marketed Drugs: Evaluation of Safety Signals, originally published in 1998;
  • Real-World Data and Real-World Evidence in Regulatory Decision Making (CIOMS XIII);
  • Severe Cutaneous Adverse Reactions of Drugs (SCARs).

Download - CIOMS Cumulative Pharmacovigilance Glossary: Version 1.1
Picture1.png (89.89 KiB) Viewed 585 times

Required faculties for pharmaceutics and pharmaceu[…]

Discriminatory dissolution method, its significanc[…]

Muthoot Hospital PTA is a hospital & healt[…]

1. PharmD Course Duration: PharmD: 6 Years (5[…]

PharmD Info - Highlights